These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

976 related articles for article (PubMed ID: 27084936)

  • 1. The delivery of therapeutic oligonucleotides.
    Juliano RL
    Nucleic Acids Res; 2016 Aug; 44(14):6518-48. PubMed ID: 27084936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular uptake and intracellular trafficking of antisense and siRNA oligonucleotides.
    Juliano RL; Ming X; Nakagawa O
    Bioconjug Chem; 2012 Feb; 23(2):147-57. PubMed ID: 21992697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides.
    Juliano R; Alam MR; Dixit V; Kang H
    Nucleic Acids Res; 2008 Jul; 36(12):4158-71. PubMed ID: 18558618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptides for nucleic acid delivery.
    Lehto T; Ezzat K; Wood MJA; El Andaloussi S
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):172-182. PubMed ID: 27349594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted delivery systems for oligonucleotide therapeutics.
    Yu B; Zhao X; Lee LJ; Lee RJ
    AAPS J; 2009 Mar; 11(1):195-203. PubMed ID: 19296227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioconjugates for targeted delivery of therapeutic oligonucleotides.
    Ming X; Laing B
    Adv Drug Deliv Rev; 2015 Jun; 87():81-9. PubMed ID: 25689735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligonucleotide delivery: a patent review (2010 - 2013).
    Grijalvo S; Aviñó A; Eritja R
    Expert Opin Ther Pat; 2014 Jul; 24(7):801-19. PubMed ID: 24798406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligonucleotides and oligonucleotide conjugates: a new approach for cancer treatment.
    Da Ros T; Spalluto G; Prato M; Saison-Behmoaras T; Boutorine A; Cacciari B
    Curr Med Chem; 2005; 12(1):71-88. PubMed ID: 15638731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular delivery of siRNA and antisense oligonucleotides via receptor-mediated endocytosis.
    Ming X
    Expert Opin Drug Deliv; 2011 Apr; 8(4):435-49. PubMed ID: 21381985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Covalent conjugation of oligonucleotides with cell-targeting ligands.
    Alam MR; Ming X; Nakagawa O; Jin J; Juliano RL
    Bioorg Med Chem; 2013 Oct; 21(20):6217-23. PubMed ID: 23777829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extrahepatic Targeting of Oligonucleotides with Receptor-Binding Non-Immunoglobulin Scaffold Proteins.
    Winkler J
    Nucleic Acid Ther; 2018 Jun; 28(3):137-145. PubMed ID: 29733239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver as a target for oligonucleotide therapeutics.
    Sehgal A; Vaishnaw A; Fitzgerald K
    J Hepatol; 2013 Dec; 59(6):1354-9. PubMed ID: 23770039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid-phase synthesis of oligonucleotide conjugates useful for delivery and targeting of potential nucleic acid therapeutics.
    Lönnberg H
    Bioconjug Chem; 2009 Jun; 20(6):1065-94. PubMed ID: 19175328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue-Specific Delivery of Oligonucleotides.
    Xia X; Pollock N; Zhou J; Rossi J
    Methods Mol Biol; 2019; 2036():17-50. PubMed ID: 31410789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The chemistry and biology of oligonucleotide conjugates.
    Juliano RL; Ming X; Nakagawa O
    Acc Chem Res; 2012 Jul; 45(7):1067-76. PubMed ID: 22353142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular uptake and intracellular trafficking of oligonucleotides: implications for oligonucleotide pharmacology.
    Juliano RL; Ming X; Carver K; Laing B
    Nucleic Acid Ther; 2014 Apr; 24(2):101-13. PubMed ID: 24383421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introduction and History of the Chemistry of Nucleic Acids Therapeutics.
    Gait MJ; Agrawal S
    Methods Mol Biol; 2022; 2434():3-31. PubMed ID: 35213007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Use of Tricyclo-DNA Oligomers for the Treatment of Genetic Disorders.
    Aupy P; Echevarría L; Relizani K; Goyenvalle A
    Biomedicines; 2017 Dec; 6(1):. PubMed ID: 29271929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleic acid aptamers as tools and drugs: recent developments.
    Rimmele M
    Chembiochem; 2003 Oct; 4(10):963-71. PubMed ID: 14523912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical Manipulation of the Endosome Trafficking Machinery: Implications for Oligonucleotide Delivery.
    Juliano RL
    Biomedicines; 2021 May; 9(5):. PubMed ID: 34063104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.